Prot #22267: A Parallel-Group, Randomized, Prospective, Interventional, Double-Blind, Multicenter Global Phase 3 Study to Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Addition to Standard of Care, in Participants with Chronic Kidn

Project: Research project

Project Details

StatusActive
Effective start/end date7/12/247/12/27

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (Prot #22267)